Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR | Market Cap | 1.47M +29.1% |
| Revenue (ttm) | 21.13M -28.9% |
| Net Income | -2.19M |
| EPS | -1.15 |
| Shares Out | 14.90M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 817,640 |
| Average Volume | 571,611 |
| Open | 0.1001 |
| Previous Close | 0.1000 |
| Day's Range | 0.0986 - 0.1010 |
| 52-Week Range | 0.0986 - 1.1200 |
| Beta | 0.06 |
| RSI | 24.36 |
| Earnings Date | Mar 13, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions include... [Read more]
Financial Performance
In 2024, Fidia's revenue was 17.53 million, a decrease of -38.98% compared to the previous year's 28.74 million. Losses were -9.30 million, 611.4% more than in 2023.
Financial StatementsNews
FDA Approves Ascendis Pharma's (ASND) Weekly Treatment for Achondroplasia
FDA Approves Ascendis Pharma's (ASND) Weekly Treatment for Achondroplasia
FDA Approves Novo Nordisk's Sogroya for New Pediatric Indications (NVO)
FDA Approves Novo Nordisk's Sogroya for New Pediatric Indications (NVO)
Neurogene: Stock Soars On FDA Designation For Rett Gene Therapy - I'd Remain Cautious
Why Are Shares Of Xeris Biopharma Falling Friday?
Shares of Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) are falling Friday after the company announced a patent infringement lawsuit to protect its drug, Recorlev . Xeris Biopharma Holdings stock is ...
Frozen blueberries sold in Canada and U.S. recalled over listeria contamination risk, FDA says
A U.S. company is recalling more than 25,000 kilograms of frozen blueberries that were distributed in Michigan, Oregon, Washington, Wisconsin and Canada, U.S. officials say.
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know
Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX
(RTTNews) - This week, the biotech space witnessed significant milestones, including FDA approvals, oncology drug acquisitions, and collaborations. Positive clinical trial results were reported across...
Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy
Neurogene stock jumps after FDA grants Breakthrough Therapy status to NGN-401 for Rett syndrome treatment. Importance ... Full story available on Benzinga.com
Aktiia Hilo Blood Pressure Monitor Review: Cuffless BP Tracking
The Aktiia Hilo Blood Pressure Monitor is the first cuffless monitor to be cleared by the FDA. It’s discreet, highly accurate, and simple to use
Aurobindo Pharma subsidiary receives 4 observations after US FDA inspection at Telangana facility
Aurobindo Pharma informed the stock exchanges that the United States Food and Drug Administration (US FDA) has completed an inspection...
Lupin Goa facility clears US FDA inspection with VAI classification
Lupin Limited (Lupin) has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA)...
Intellia outlines 2026 lonvo-z launch plans as FDA lifts clinical hold on MAGNITUDE-2
Neurogene Gets FDA Breakthrough Tag For NGN-401 In Rett Syndrome; Stock Up
(RTTNews) - Neurogene Inc. (NGNE) announced that the U.S. FDA has granted Breakthrough Therapy designation to NGN-401, its investigational gene therapy for Rett syndrome.
FDA minister vows to curb delivery of post-expiry date food items
Pune: State food and drugs administration minister Narhari Zirwal on Thursday admitted in the assembly that his department lacked proactiveness in tak.
FDA Grants Breakthrough Therapy Designation to Neurogene's NGN-401
FDA Grants Breakthrough Therapy Designation to Neurogene's NGN-401
FDA plans bonuses to staffers who complete speedy drug reviews
The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule.
Merck (MRK) Gains FDA Approval for Canine Allergy Treatment
Merck (MRK) Gains FDA Approval for Canine Allergy Treatment
Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths
Boston Scientific Corp (NYSE: BSX) on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment compl...
Merck wins FDA approval of Numelvi for itching in dogs
FDA reportedly eyeing staff bonuses to accelerate drug reviews
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Uniqure stock plummeted Thursday after Marty Makary appeared on CNBC to defend the FDA's recent rejections of rare disease drugs.
uniQure (QURE) Shares Affected by FDA Commentary
uniQure (QURE) Shares Affected by FDA Commentary
uniQure (QURE) Faces Investor Concerns Amid FDA Commentary
uniQure (QURE) Faces Investor Concerns Amid FDA Commentary
uniQure (QURE) Shares Plunge as FDA Casts Doubt on AMT-130 Approval
uniQure (QURE) Shares Plunge as FDA Casts Doubt on AMT-130 Approval